Choksi Laboratories Ltd
Incorporated in 1982, Choksi Laboratories Ltd provides contract testing and analytical services. Company analyzes for its clients, or as a regulatory requirement in industries such as pharmaceutical, food, engineering and
construction material.
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Jul - Certificate confirming share dematerialisation compliance for quarter ended June 30, 2025.
-
Closure of Trading Window
26 Jun - Trading window closed from July 1, 2025 till 48 hours post Q1 June 2025 results declaration.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Jun - Extract of Audited Financial Results for the quarter and financial year ended 31st March, 2025 has been published in the newspaper
- Financial Result For Quarter And Year Ended 31.03.2025 7 Jun
-
Board Meeting Outcome for Outcome Of Board Meeting Dated 07Th June, 2025
7 Jun - Audited FY25 results approved; disclosed May 2025 ransomware attack causing temporary disruption.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1]
a) Contract Laboratory Services (CLS):[2]
Company provides four different analysis under CLS, viz.
Pharmaceutical Analysis
Food & Beverages Analysis
Water Analysis
Construction Material Analysis
b) Instrument Calibration & Validation Services:[3] Company provides Laboratory and On-Site calibration for test equipment, process equipment, and in many cases end-user equipment, Plant Shutdown Calibration, and consultancy for setting up an in-house calibration laboratory.
c) Environmental Management Services:[4]
Company helps industries develop their Waste Disposal and Effluent Treatment capabilities along with Air Pollution Monitoring, and Waste Water Management
d) Clinical Research Services:[5]
Company has developed a 40-bed clinical research facility for carrying out Bio-Availability and Bio-Equivalence studies
e) Consultancy:[6]
Company provides Training, Auditing, and Consultancy for organizations
f) Assaying & Hallmarking:[7]
Company has set up a gold & silver hallmarking center with EDXRF, Laser assisted marking machine and fire-assay facilities.